Prevalence of Pediatric-Onset Chronic Conditions, Functional Limitations Increasing
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 19, 2025 -- The prevalence of chronic conditions (CC) and functional limitations (FL) is increasing among children and young adults, according to a study published online March 7 in Academic Pediatrics.
Lauren E. Wisk, Ph.D., from the David Geffen School of Medicine at the University of California, Los Angeles, and Niraj Sharma, M.D., M.P.H., from Brigham and Women's Hospital in Boston, examined the current prevalence and recent trends in pediatric-onset conditions in a secondary analysis of data from 236,412 participants, aged 5 to 25 years, from the 1999 to 2018 National Health Interview Survey.
The researchers found an increase in the prevalence of children (aged 5 to 17 years) with a CC/FL, from 22.57 percent in 1999/2000 to 30.21 percent in 2017/2018, representing a 0.24 percentage point adjusted annual increase per year or about 130,000 additional children per year. A similar increase was seen in the prevalence of young adults (18 to 25 years) with a CC/FL (adjusted annual increase of 0.33 percentage points per year). For both age groups, asthma and mental/behavioral health conditions were some of the leading CC and FL contributors to this increase, respectively. An estimated 1.2 million youth with a CC or FL turn 18 years old each year.
"Given the unprecedented number of youth with these pediatric-onset conditions, it is incumbent for the overall health care system to not only treat these youth in the pediatric setting but also seek ways to matriculate them into adult care so that their conditions are successfully managed across their life course," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-20 06:00
Read more

- CagriSema Demonstrates Superior Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes in the REDEFINE 2 Trial
- Reported Breast, Colorectal Cancer Screening Higher in 2023 Than 2019
- How To Talk to Your Child About a Cancer Diagnosis
- Study Finds Organ Health May Predict Dementia, Cancer Later in Life
- Henlius Receives Orphan-Drug Designation for HLX22 (Innovative anti-HER2 mAb) in the U.S. for Gastric Cancer
- Glucose Monitors Improve Traffic Safety For Diabetic Drivers
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions